Metabolic engineering of doxorubicin biosynthesis through P450-redox partner optimization and structural analysis of DoxA

2026-02-04 | Metabolic engineering of doxorubicin biosynthesis through P450-redox partner optimization and structural analysis of DoxANat. Commun. Koroleva, A.; Artukka, E.; Yamada, K.; Newmister, S. A.; Harte, R. J.; Boesger, H.; Londen, M.; Sanders, J. N.; Tirkkonen, H.; Kannisto, M.; Kuin, R. C. M.; Hulst, M.; Wang, R.; Leskinen, E.; Barillec, M.; Niemi, J.; van Wezel, G. P.; Neefjes, J.; Nybo, S. E.; Houk,* K. N.; Sherman, D. H.; Kim, R. Q.; Metsä-Ketelä, M.